Dosidal · Switzerland

Xarelto junior, Granulat zur Herstellung einer Suspension zum Einnehmen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67701 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67701
atc: B01AF01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2021-06-02
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: B01AF01
authorisation_number: 67701
form: GRAS
holder: Bayer (Schweiz) AG
holder_partner_nr: 1000372
it_number: 06.03.0.
name: Xarelto junior, Granulat zur Herstellung einer Suspension zum Einnehmen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
thh0r2z2WnqzFPCeYZ_YiWeqS2wmNPeZ-FFjBUxwb-6iiy_kmJmNtS5x1m2fkWrU8Vwdvnya18Uz0n_WYa7-Ww
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal